| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |